Literature DB >> 25106812

Association of hypercholesterolemia and cardiac function evaluated by speckle tracking echocardiography in a rabbit model.

Liyun Liu, Yuming Mu1, Wei Han, Chunmei Wang.   

Abstract

BACKGROUND: Although hypercholesterolemia is a major risk factor for coronary artery disease (CAD), only limited data are available regarding its direct effect on myocardial function apart from CAD. The aim of this study was to evaluate LV systolic function using speckle-tracking echocardiography and investigate the relationship between hypercholesterolemia and myocardial function.
METHODS: Twenty-eight rabbits were randomly divided into three groups: 8 were fed normal chow for 3 months (group 1) and the remaining 20 were fed an atherogenic diet for 2 (group 2) or 3 months (group 3). Global systolic radial, circumferential and longitudinal peak strain were calculated. Serum total cholesterol (TC), low density lipoprotein cholesterol (LDL-C) and myocardial cholesterol levels were measured.
RESULTS: Global systolic longitudinal strain were both decreased in the group 2 and 3 (P < 0.001), whereas radial strain were increased (P < 0.001) compared with group 1. Global circumferential strain in the group 3 was significantly reduced (P < 0.001). Serum and myocardial cholesterol concentration markedly increased in the group 2 and group 3 (P < 0.001). There was a significant inverse correlation between longitudinal strain and serum TC, LDL-C as well as myocardial cholesterol levels (r = - 0.723, r = - 0.794, r = - 0.700, P both < 0.001). A significant negative correlation was also noted between circumferential strain and serum TC, LDL-C as well as myocardial cholesterol levels (r = - 0.518, P = 0.007; r = - 0.691, P < 0.001; r = - 0.659, P < 0.001). A significant positive correlation was found between radial strain and serum TC, LDL-C as well as myocardial cholesterol levels (r = 0.432, P = 0.028; r = 0.602, P = 0.001; r = 0.469, P = 0.016).
CONCLUSION: Although LV morphology and ejection fractions were not different among the three groups, elevated concentration of cholesterol, especially in serum LDL-C, was significantly associated with LV systolic dysfunction. The findings also indicate that reductions in longitudinal was the first appeared, followed by circumferential, and was compensated for by increasing radial strain.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25106812      PMCID: PMC4245723          DOI: 10.1186/1476-511X-13-128

Source DB:  PubMed          Journal:  Lipids Health Dis        ISSN: 1476-511X            Impact factor:   3.876


Background

Although hypercholesterolemia has emerged as a strong risk factor for coronary artery disease (CAD) [1-3], only limited data are available regarding its direct effect on myocardial function apart from CAD [4-6]. The metabolic derangement of hypercholesterolemia can result in abnormalities of cardiac function that are likely independent of effects on the vasculature [5]. While single left ventricular (LV) myocytes isolated from hypercholesterolemic rabbits demonstrated a significant reduction in systolic function without any change in blood pressure or LV morphology [4], few data are available from in vivo investigations. Speckle tracking echocardiography (STE), a relatively new echocardiographic imaging modalities, offers an objective and quantitative evaluation of global and regional myocardial deformation in longitudinal, radial and circumferential directions [7-9]. A large amount of published data has described that STE could detect subtle changes in LV function at an early subclinical stage [10-13]. The aim of the present study was to elucidate whether dietary hypercholesterolemia alters LV systolic function independently of CAD using STE in rabbits model and investigate their relationship.

Methods

Animal model

The experimental protocol was approved by a local ethical committee (First Affiliated Hospital, Xinjiang Medical University, Xinjiang, China). Twenty-eight male New Zealand rabbits (1.9-2.3 kg) were housed in separate cages in an environmentally controlled facility (AAALAC accredited) and were given water ad libitum and received humane care in compliance with institutions guidelines. The rabbits were acclimatized to laboratory conditions for 7 days prior to treatment. Eight rabbits were fed normal chow for 3 months as control (group 1) and the remaining 20 accepted an atherogenic diet for 2 months (group 2) or 3 months (group 3). The atherogenic diet contained 84% standard chow diet, 5% lard, 5% egg yolk powder and 2% cholesterol [13]. Diarrhea, appetite and coat color were observed during the experimental period.

Echocardiographic imaging

On the day of the study, rabbits fast for approximately 4 h to reduce abdominal distention and to facilitate obtaining the images. Echocardiographic images were acquired after lightly sedated with 10 mg/kg ketamine (Fujian Gutian Pharmaceutical Co., Ltd, China), 1 mg/kg Diazepam (Tianjin Jinyao Amino Acid Co., Ltd, China) and 0.025 mg/kg Atropine (Tianjin Pharmaceutical Group Co., Ltd, China) administered intravenously. The rabbits were placed in prone position without restraint. All images were obtained using a commercial ultrasound machine (Vivid 7 Dimension; GE Vingmed Ultrasound AS, Horten, Norway) with an M5S probe. M- mode images of parasternal long-axis view, B-mode images of apical three-chamber, four-chamber, and two-chamber views, short-axis views at the level of the mitral valve, papillary muscles, and apex were obtained and digitally stored in cine-loop format for off line analysis [14]. LV end-diastolic diameter (LVEDd), LV end-systolic diameter (LVEDs), septal and LV posterior wall thickness, and left atrial anteroposterior diameter (LAD) were measured from standard planes. LV ejection fraction (EF) was calculated with the Teicholz formula [15].

Strain analysis

Two-dimensional B-mode images were captured with a frame rate of 50–80 fps and five beats were recorded for analysis. Blinded offline analyses of the short-axis views and apical long-axis views were performed using EchoPAC PC version 6.1.1 (GE Vingmed Ultrasound AS, Horten, Norway). After selecting the best-quality image of the cardiac cycle, the LV endocardial border was manually traced at the end-systolic frame, from which a speckle-tracking region of interest was automatically selected to approximate the myocardium between the endocardium and epicardium [16]. The workstation then computed and generated strain curves. The software automatically divided the sectional image into six segments according to the statement of the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association [17] (Figure 1). Strain curves of three consecutive cardiac cycles and values were imported for further analysis. To determine global longitudinal, circumferential and radial strain, the strain values of the 18 segments were averaged for the apical views or the short-axis views.
Figure 1

Systolic radial stain of the six myocardial segments.

Systolic radial stain of the six myocardial segments.

Blood pressure measurement

After echocardiographic imaging, blood pressure measurements were made from the central ear artery (CEA) of rabbits using a 20G vascular catheter (Johnson and Johnson, Belgium). The arterial catheter was connected to a pressure transducer (MLT0699, AD Instruments, Pty Ltd, Australia) and an analog-to-digital converter (PowerLab, ML866, AD Instruments, Pty Ltd, Australia). Arterial systolic and diastolic pressure were recorded.

Cholesterol analysis

Peripheral blood was collected from ear veins with a 25-gauge needle and syringe at baseline, 2 months and 3 months. Total cholesterol (TC) and low density lipoprotein cholesterol (LDL-C) were measured with an automated clinical chemistry analyzer (AU680, Beckman Instruments, USA). All rabbits were euthanized at correspnding time and the hearts removed. A segment of myocardial tissue (10 × 3 mm) from the LV free wall was excised. Cholesterol levels were measured in the tissue segment using a cholesterol Kit (EnzyChrom Cholesterol Assay Kit, BioAssay Systems, Hayward, CA).

Statistical analysis

SPSS 16.0 (SPSS inc., Chicago, Illinois, USA) was used for statistical analysis. The data were tested for normality and homogeneity of variance. Data are expressed as mean ± standard deviation (SD). One way ANOVA was used to compare the echocardiographic parameters, strain parameters, myocardial and serum cholesterol levels for all three groups. Pearson correlation analysis was done between STE variables and cholesterol levels. For all analyses, a P value < 0.05 was considered significant. Interobserver and intraobserver variability for strain measurements were examined using both Pearson’s bivariate two-tailed correlations and Bland-Altman analysis from 10 randomly selected rabbits.

Results

Animal

Of the 28 experimental rabbits, 1 died in the group 3 due to diarrhea. Heart rates and blood pressure of three groups were similar (P > 0.05, Table 1).
Table 1

General characteristics of the study animals

ParametersGroup 1 n = 8Group 2 n = 10Group 3 n = 9 F-value P-value
HR (beats/min)183.50 ± 9.49168.30 ± 9.32187.89 ± 11.022.210.13
SBP (mmHg)109.88 ± 11.31110.50 ± 8.37111.22 ± 10.330.120.88
DBP (mmHg)78.25 ± 8.0577.50 ± 10.8482.67 ± 10.060.730.49

HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure.

General characteristics of the study animals HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure.

Conventional echocardiography

Echocardiographic measurements of the different groups were shown in Table 2. There were no significant differences in LVEF, LVEDd, LVEDs, IVS, PW and LAD among three groups (P > 0.05).
Table 2

Comparison of echocardiographic parameters

ParametersGroup1 n = 8Group2 n = 10Group3 n = 9 F-value P-value
LVEDd (mm)13.14 ± 1.4313.51 ± 1.6913.33 ± 1.580.120.89
LVEDs (mm)8.62 ± 0.869.00 ± 1.028.81 ± 0.920.370.70
IVS (mm)2.12 ± 0.311.88 ± 0.362.08 ± 0.371.280.30
PW (mm)2.04 ± 0.222.01 ± 0.202.23 ± 0.381.630.22
LVEF (%)67.38 ± 4.6365.97 ± 4.6166.93 ± 3.730.250.78
LAD (mm)8.84 ± 1.159.94 ± 1.239.42 ± 0.990.660.53

LVEDd, left-ventricular end-diastolic diameter; LVEDs, left-ventricular end-systolic diameter; EF, ejection fraction; LAD, left-atrial diameter; IVS, ventricular septal end-diastolic thickness; PW, posterior wall end-diastolic thickness.

Comparison of echocardiographic parameters LVEDd, left-ventricular end-diastolic diameter; LVEDs, left-ventricular end-systolic diameter; EF, ejection fraction; LAD, left-atrial diameter; IVS, ventricular septal end-diastolic thickness; PW, posterior wall end-diastolic thickness.

Strain measurements

From a total of 972 analyzed segments, 28 segments were excluded owing to suboptimal myocardial tracking and poor image quality. Regional longitudinal (Table 3) and circumferential (Table 4) strain of LV were significantly reduced in group 3 compared with group 1 and 2. But regional radial strain of LV were significantly increased in group 3 (Table 5).Global longitudinal myocardial deformation of the LV was significantly impaired both in group 2 and 3, while radial deformation was increased in group 3 compared with group 1 and 2. In addition, global circumferential strain was also reduced in group 3 compared with group 1 and 2 (Figure 2).
Table 3

Peak systolic longitudinal strain values

Longitudinal strain (%)Group 1 n = 8Group 2 n = 10Group 3 n = 9 F-value P-value
A4C septum
Basal segment-21.76 ± 3.28-21.97 ± 4.08-18.87 ± 2.152.2400.129
Mid segment-23.40 ± 4.38-21.89 ± 3.47-18.91 ± 2.20*3.4930.047
Apical segment-24.54 ± 5.57-22.08 ± 4.32-19.41 ± 3.06*2.6850.090
A4C lateral wall
Basal segment-23.64 ± 4.44-21.96 ± 3.31-18.30 ± 1.69* 5.3820.019
Mid segment-20.88 ± 3.74-20.98 ± 3.20-18.32 ± 2.011.9450.166
Apical segment-22.94 ± 3.36-21.90 ± 3.48-19.28 ± 4.212.1150.143
A3C posterior wall
Basal segment-22.74 ± 3.21-20.89 ± 2.38-18.87 ± 3.35*3.4250.050
Mid segment-21.71 ± 2.68-22.05 ± 2.65-18.57 ± 3.13* 3.9240.034
Apical segment-23.77 ± 2.78-21.15 ± 3.47-21.60 ± 4.271.3270.285
A3C anterior septum
Basal segment-21.31 ± 3.34-20.92 ± 3.54-19.41 ± 2.790.7640.477
Mid segment-21.96 ± 2.95-21.09 ± 3.70-19.62 ± 3.680.8370.446
Apical segment-22.28 ± 2.24-22.59 ± 2.87-18.86 ± 3.55* 4.1970.028
A2C inferior wall
Basal segment-25.78 ± 4.34-20.90 ± 2.74*-19.36 ± 3.19*7.7490.003
Mid segment-23.37 ± 4.53-20.02 ± 2.59-19.08 ± 3.61*3.2050.059
Apical segment-24.54 ± 4.51-21.23 ± 2.34-21.57 ± 4.232.0270.155
A2C anterior wall
Basal segment-23.64 ± 4.28-21.75 ± 2.34-18.96 ± 3.24*4.0660.031
Mid segment-23.17 ± 3.39-23.37 ± 2.68-17.82 ± 3.00* 9.1400.001
Apical segment-24.28 ± 5.70-23.59 ± 3.90-21.10 ± 4.141.0750.358

Data are expressed as mean ± SD. A4C, Apical four-chamber; A3C, apical three-chamber; A2C, apical two-chamber. *p < 0.05 for group 3 and group 2 vs. group 1, ▲ p < 0.05 for group 3 vs. group 2.

Table 4

Peak systolic circumferental strain values

Circumferental strain (%)Group 1 n = 8Group 2 n = 10Group 3 n = 9 F-value P-value
Mitral valve level
Anteroseptal wall-30.18 ± 5.52-30.33 ± 5.91-23.45 ± 6.55* 3.5710.045
Anterior wall-23.76 ± 4.86-23.22 ± 4.42-20.09 ± 2.331.9390.167
Lateral wall-20.63 ± 5.89-19.75 ± 3.35-19.10 ± 3.190.2630.771
Posterior wall-21.40 ± 4.46-20.85 ± 4.58-18.65 ± 3.250.8690.433
Inferior wall-22.58 ± 4.22-20.89 ± 4.59-17.34 ± 3.73*3.2150.059
Septal wall-27.99 ± 6.30-27.83 ± 6.71-21.75 ± 4.45* 2.9370.073
Papillary level
Anteroseptal wall-28.22 ± 7.03-29.73 ± 6.00-24.80 ± 4.061.6190.22
Anterior wall-20.58 ± 3.78-22.99 ± 4.44-19.76 ± 2.891.7760.192
Lateral wall-18.99 ± 3.19-20.18 ± 3.17-18.31 ± 2.040.9820.39
Posterior wall-19.32 ± 3.52-19.73 ± 3.31-19.45 ± 1.060.0470.954
Inferior wall-21.01 ± 3.60-20.59 ± 2.33-17.19 ± 1.89* 5.0470.015
Septal wall-27.98 ± 7.59-28.21 ± 5.53-20.66 ± 3.03* 4.7170.019
Apical level
Anteroseptal wall-30.24 ± 6.67-28.71 ± 6.29-21.53 ± 3.78* 5.2840.013
Anterior wall-25.66 ± 5.46-23.68 ± 5.03-19.68 ± 2.60*3.5390.046
Lateral wall-24.88 ± 4.33-22.72 ± 6.18-19.48 ± 3.25*2.1920.134
Posterior wall-25.33 ± 5.92-23.65 ± 3.84-19.49 ± 3.06*3.7820.038
Inferior wall-25.81 ± 5.45-23.46 ± 5.93-18.66 ± 2.86*4.2280.027
Septal wall-26.64 ± 6.78-27.42 ± 6.34-24.85 ± 5.080.5530.582

Data are expressed as mean ± SD. *p < 0.05 for group 3 and group 2 vs. group 1, ▲p < 0.05 for group 3 vs. group 2.

Table 5

Peak systolic radial strain values

Radial strain (%)Group 1 n = 8Group 2 n = 10Group 3 n = 9 F-value P-value
Mitral valve level
Anteroseptal wall36.84 ± 6.9838.88 ± 6.1645.48 ± 6.85* 3.7560.039
Anterior wall37.92 ± 7.1540.48 ± 8.0644.77 ± 9.821.3680.275
Lateral wall41.65 ± 7.7842.02 ± 9.1246.48 ± 9.370.7650.477
Posterior wall39.65 ± 5.4144.31 ± 7.0649.07 ± 6.21* 4.4260.024
Inferior wall40.92 ± 5.3142.54 ± 7.6450.13 ± 7.02* 4.2310.027
Septal wall38.09 ± 7.2140.84 ± 7.2147.40 ± 5.41* 4.0980.03
Papillary level
Anteroseptal wall37.41 ± 5.0138.11 ± 5.3844.81 ± 10.12* 2.7260.087
Anterior wall37.06 ± 7.4537.83 ± 6.5639.28 ± 7.310.2050.816
Lateral wall42.32 ± 7.8139.45 ± 7.2742.05 ± 9.370.3510.708
Posterior wall42.54 ± 7.1444.24 ± 3.8146.22 ± 11.700.4320.654
Inferior wall43.18 ± 8.5442.40 ± 4.8745.67 ± 6.380.5740.571
Septal wall39.85 ± 8.4541.14 ± 6.8748.49 ± 6.96* 3.230.058
Apical level
Anteroseptal wall39.10 ± 6.7038.63 ± 5.9043.96 ± 6.631.8020.187
Anterior wall37.29 ± 6.4438.84 ± 5.8444.71 ± 4.59* 3.880.035
Lateral wall43.85 ± 8.8440.85 ± 3.9747.66 ± 9.67* 3.1590.061
Posterior wall41.17 ± 7.3741.74 ± 6.8844.07 ± 12.150.2410.788
Inferior wall44.52 ± 6.6642.14 ± 8.8544.90 ± 7.490.3360.718
Septal wall42.44 ± 6.0638.34 ± 5.8446.96 ± 10.41 2.880.076

Data are expressed as mean ± SD. *p < 0.05 for group 3 and group 2 vs. group 1, ▲p < 0.05 for group 3 vs. group 2.

Figure 2

Global peak systolic longitudinal, circumferential and radial strain in the three groups. *p < 0.001 for group 3 vs. group 2 and group 1. ▲p < 0.05 for group 2 vs group 1.

Peak systolic longitudinal strain values Data are expressed as mean ± SD. A4C, Apical four-chamber; A3C, apical three-chamber; A2C, apical two-chamber. *p < 0.05 for group 3 and group 2 vs. group 1, ▲ p < 0.05 for group 3 vs. group 2. Peak systolic circumferental strain values Data are expressed as mean ± SD. *p < 0.05 for group 3 and group 2 vs. group 1, ▲p < 0.05 for group 3 vs. group 2. Peak systolic radial strain values Data are expressed as mean ± SD. *p < 0.05 for group 3 and group 2 vs. group 1, ▲p < 0.05 for group 3 vs. group 2. Global peak systolic longitudinal, circumferential and radial strain in the three groups. *p < 0.001 for group 3 vs. group 2 and group 1. ▲p < 0.05 for group 2 vs group 1.

Serum and tissue cholesterol profiles

The serum cholesterol profiles of the three groups after experiment were shown in Table 6. There was a statistically significant increase in serum TC, LDL-C and tissue cholesterol levels in animals fed with cholesterol enriched diet compared with the control group (p <0.05). Morerove, the concentration of cholesterol increased with feeding duration (p <0.05).
Table 6

Serum and tissue cholesterol profiles

ParametersGroup 1 n = 8Group 2 n = 10Group 3 n = 9 F-value P-value
Serum TC (mmol/L)2.07 ± 0.6024.15 ± 5.36* 34.74 ± 10.40* 191.270.000
Serum LDL-C (mmol/L)1.13 ± 0.5410.73 ± 3.32* 31.62 ± 3.68* 229.600.000
Tissue cholesterol(μmol/g)0.86 ± 0.292.22 ± 0.62* 4.92 ± 1.63* 34.680.000

Data are expressed as mean ± SD. TC, total cholesterol; LDL-C, low density lipoprotein cholesterol.

*p < 0.05 for group 3 and group 2 vs. group 1, ▲p < 0.05 for group 3 vs. group 2.

Serum and tissue cholesterol profiles Data are expressed as mean ± SD. TC, total cholesterol; LDL-C, low density lipoprotein cholesterol. *p < 0.05 for group 3 and group 2 vs. group 1, ▲p < 0.05 for group 3 vs. group 2.

Correlation between strain parameters and cholesterol levels

The correlation between strain parameters and cholesterol were shown in Table 7. There was significant inverse correlation between global longitudinal strain and serum TC, LDL-C as well as myocardial cholesterol levels. (r = - 0.723, P < 0.001; r = - 0.794, P < 0.001; r = - 0.70, P < 0.001). A significant negative correlation was also noted between global circumferential strain and serum TC, LDL-C as well as myocardial cholesterol levels. (r = - 0.518, P = 0 .007; r = - 0.691, P < 0.001; r = - 0.659, P < 0.001). A significant positive correlation was found between radial strain and serum TC, LDL-C as well as myocardial cholesterol levels. (r = 0.432, P = 0.028; r = 0.602, P = 0.001; r = 0.469, P = 0.016).
Table 7

Correlation between strain paramters and cholesterol

Strain parametersSerum TCSerum LDL -CTissue cholesterol
r p r p r p
GLS-0.7230.000-0.7940.000-0.7000.000
GRS0.4320.0280.6020.0010.4690.016
GCS-0.5180.007-0.6910.000-0.6590.000

GLS, global longitudinal strain; GRS, global radial strain; GCS, global circumferential strain; TC, total cholesterol; LDL-C, low density lipoprotein cholesterol.

Correlation between strain paramters and cholesterol GLS, global longitudinal strain; GRS, global radial strain; GCS, global circumferential strain; TC, total cholesterol; LDL-C, low density lipoprotein cholesterol.

Reproducibility

The results showed very good intra-observer variability for longitudinal, circumferential and radial strain rate (r = 0.817, P = 0.004; r = 0.798, P = 0.006; r = 0.868, P = 0.001). The Bland-Altman plots demonstrated acceptable inter-observer variability for all strain parameters (Figure 3).
Figure 3

Inter-observer variability for global longitudinal (left), circumferential (middle) and radial strain (right).

Inter-observer variability for global longitudinal (left), circumferential (middle) and radial strain (right).

Discussion

To the best of our knowledge, the present study is the first to comprehensively compare strain parameters-derived STI with the levels of serum and myocardial cholesterol in diet-induced expeimental hypercholesterolemia. Although previous experimental studies have shown that diet-induced hypercholesterolemia resulted in contractile reduction of single ventricular myocyte without any change in pressure or LV morphology [4], few data are available from in vivo investigations. The present study displayed the application of STE as a noninvasive imaging technique to elucidate the direct effect of hypercholesterolemia on LV myocardial deformation in a rabbit model. In our study, there were no significant differences in LV morphology, EF and blood pressure among groups, whereas LV strain was found to be reduced in the hypercholesterolemic rabbits. Previous studies failed to show abnormalities using EF, which may be due to EF reflects the whole LV systolic function, under the influence of pre and afterload [18]. With the application of advanced techniques, such as strain, strain rate, incipient systolic dysfunction has been detected in subclinical diseases [19]. Moreover, our analysis indicates that longitudinal dysfunction are the first appeared, followed by circumferential, which suggest the importance of longitudinal strain in the assessment of LV systolic dysfunction in subclinical stage. Whether similar changes occur in humans with hypercholesterolemia can not confirm from our study. However, a recent human study demontrated longitudinal and circumferential deformations were both impaired in the children with heterozygous familiar hypercholesterolemia [20]. Thus, we believe that the abnormalities we found in rabbit models with hypercholesterolemia indicate an early sign of hypercholesterolemia-induced myocardial dysfunction, in agreement with the in vitro expriments [4]. Interestingly, our study demonstrates that the increased radial deformation make up for impaired longitudinal and circumferential strain in rabbit hypercholesterolemic models to maintain LVEF. This finding is consistent with prior reports in children with heterozygous familial hypercholesterolemia and other preclinical diseases [14, 20, 21]. The potential mechanism by which hypercholesterolemia causes the increase in radial deformation remains unclear. A possible explanation could be the realignments of myocardial fiber orientation in the outer half of the myocardium may contribute to “transmural compensation” by less impaired epicardial fibers [22]. In the present study, a significant negative correlation were found between global longitudinal strain and serum cholesterol level as well as myocardial cholesterol levels. These results indicate that the cholesterol accumulated in the myocardium may be responsible for a reduction in myocardial strain. Similar to our study, Wang et al. [23] reported a positive correlation between serum HDL levels and LVEF in human subjects with serum hypercholesterolemia even in the absence of angiographic evidence of CAD. The precise mechanism responsible for the association between cholesterol level and impaired myocardial deformation cannot be determined from our study. However, several mechanisms have been proposed to explain LV dysfunction induced by hypercholesterolemia: (1) increased cardiac oxidative stress [24], (2) alteration of the myocardial energy metabolism [22], (3) changes in myosin heavy-chain isoform expression patterns [4], (4) down-regulation and redistribution of connexin-43 expression in myocardium [25], and (5) impaired activation of myocardial adenosine triphosphate-sensitive potassium channels [19]. These mechanisms may represent the basis for a “hypercholesterolemic cardiomyopathy [26].

Study limitations

As a limitations of our study, administration of ketamine- Diazepam - Atropine combinations induces mild bradycardia, which slightly alters cardiac function. In addition, LV diastolic function, rotation and torsion mechanics are potentially very important features for the comprehensive understanding of myocardial tissue damage; therefore, lack of measurement of diastolic function, rotation and torsion was another limitation of the present study.

Conclusion

Hypercholesterolemia was significantly associated with LV myocardial functional alterations apart from CAD. The findings also indicate that decreases in longitudinal was the first appeared, followed by circumferential, and was compensated for by increasing radial strain. Thus, the application of STE may provide noninvasive functional insight into disease progression or recovery in reponse to therapeutic intervention.
  25 in total

1.  Cardiac systolic and diastolic dysfunction after a cholesterol-rich diet.

Authors:  Y Huang; K E Walker; F Hanley; J Narula; S R Houser; T N Tulenko
Journal:  Circulation       Date:  2003-12-15       Impact factor: 29.690

2.  Effect of hypercholesterolemia on myocardial function in New Zealand white rabbits.

Authors:  Tsai-Yueh Luo; Ming-Jai Su; Yi-Fan Yang; Yen-Bin Liu; Hsiu-Chuan Liang; Chau-Chung Wu; Yuan-Teh Lee
Journal:  J Biomed Sci       Date:  2004 Nov-Dec       Impact factor: 8.410

3.  Importance of left ventricular longitudinal function and functional reserve in patients with degenerative mitral regurgitation: assessment by two-dimensional speckle tracking.

Authors:  Patrizio Lancellotti; Bernard Cosyns; Dimitris Zacharakis; Emilio Attena; Guy Van Camp; Olivier Gach; Marc Radermecker; Luc A Piérard
Journal:  J Am Soc Echocardiogr       Date:  2008-12       Impact factor: 5.251

4.  Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study.

Authors:  J He; L G Ogden; L A Bazzano; S Vupputuri; C Loria; P K Whelton
Journal:  Arch Intern Med       Date:  2001-04-09

5.  Association of pravastatin and left ventricular mass in hypercholesterolemic patients: role of 8-iso-prostaglandin f2alpha formation.

Authors:  Tsung-Ming Lee; Tsai-Fwu Chou; Chang-Her Tsai
Journal:  J Cardiovasc Pharmacol       Date:  2002-12       Impact factor: 3.105

6.  Downregulated myocardial connexin 43 and suppressed contractility in rabbits subjected to a cholesterol-enriched diet.

Authors:  Lung-Chun Lin; Chau-Chung Wu; Hung-I Yeh; Long-Sheng Lu; Yen-Bin Liu; Shien-Fong Lin; Yuan-Teh Lee
Journal:  Lab Invest       Date:  2005-10       Impact factor: 5.662

7.  Effect of clopidogrel on the inflammatory progression of early atherosclerosis in rabbits model.

Authors:  Ming Li; Yijing Zhang; Hongsheng Ren; Yuanchao Zhang; Xinglei Zhu
Journal:  Atherosclerosis       Date:  2006-12-06       Impact factor: 5.162

8.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.

Authors:  R M Conroy; K Pyörälä; A P Fitzgerald; S Sans; A Menotti; G De Backer; D De Bacquer; P Ducimetière; P Jousilahti; U Keil; I Njølstad; R G Oganov; T Thomsen; H Tunstall-Pedoe; A Tverdal; H Wedel; P Whincup; L Wilhelmsen; I M Graham
Journal:  Eur Heart J       Date:  2003-06       Impact factor: 29.983

9.  Relationship between longitudinal and radial contractility in subclinical diabetic heart disease.

Authors:  Zhi You Fang; Rodel Leano; Thomas H Marwick
Journal:  Clin Sci (Lond)       Date:  2004-01       Impact factor: 6.124

10.  Early impairment of left ventricular function in hypercholesterolemia and its reversibility after short term treatment with rosuvastatin A preliminary echocardiographic study.

Authors:  Enrica Talini; Vitantonio Di Bello; Cristina Bianchi; Caterina Palagi; Maria Grazia Delle Donne; Giuseppe Penno; Carmela Nardi; Maria Laura Canale; Stefano Del Prato; Mario Mariani; Roberto Miccoli
Journal:  Atherosclerosis       Date:  2007-07-13       Impact factor: 5.162

View more
  8 in total

1.  Effects of obesity and metabolic syndrome on cardiovascular outcomes in pediatric kidney transplant recipients: a longitudinal study.

Authors:  Kristen Sgambat; Sarah Clauss; K Y Lei; Jiuzhou Song; Shaik O Rahaman; Margaret Lasota; Asha Moudgil
Journal:  Pediatr Nephrol       Date:  2017-12-30       Impact factor: 3.714

2.  Myocardial function in primary antiphospholipid syndrome using speckle-tracking echocardiography.

Authors:  Gabriela Medina; Eduardo Gómez-Bañuelos; Erick Calderón-Aranda; María Pilar Cruz-Domínguez; Olga Vera-Lastra; Luis J Jara
Journal:  Clin Rheumatol       Date:  2018-04-19       Impact factor: 2.980

3.  The hematologic effects of low intensity 650 nm laser irradiation on hypercholesterolemia rabbits.

Authors:  Hong Wang; Juan Deng; Wenjun Tu; Lin Zhang; Hongli Chen; Xiaoguang Wu; Yingxin Li; Hong Sha
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

Review 4.  Modulation of Hypercholesterolemia-Induced Oxidative/Nitrative Stress in the Heart.

Authors:  Csaba Csonka; Márta Sárközy; Márton Pipicz; László Dux; Tamás Csont
Journal:  Oxid Med Cell Longev       Date:  2015-12-14       Impact factor: 6.543

5.  Future Perspectives for Management of Stage A Heart Failure.

Authors:  Hidekazu Tanaka
Journal:  J Atheroscler Thromb       Date:  2018-05-07       Impact factor: 4.928

6.  A Comorbidity Model of Myocardial Ischemia/Reperfusion Injury and Hypercholesterolemia in Rat Cardiac Myocyte Cultures.

Authors:  András Makkos; Ágnes Szántai; János Pálóczi; Judit Pipis; Bernadett Kiss; Paola Poggi; Péter Ferdinandy; Alexandros Chatgilialoglu; Anikó Görbe
Journal:  Front Physiol       Date:  2020-01-09       Impact factor: 4.566

7.  Diet-Induced Hypercholesterolemia Leads to Cardiac Dysfunction and Alterations in the Myocardial Proteome.

Authors:  Márton Richárd Szabó; Márton Pipicz; Márta Sárközy; Bella Bruszel; Zoltán Szabó; Tamás Csont
Journal:  Int J Mol Sci       Date:  2022-07-02       Impact factor: 6.208

8.  Cholesterol remnants and triglycerides are associated with decreased myocardial function in patients with type 2 diabetes.

Authors:  Peter Godsk Jørgensen; Magnus Thorsten Jensen; Tor Biering-Sørensen; Rasmus Mogelvang; Søren Galatius; Thomas Fritz-Hansen; Peter Rossing; Tina Vilsbøll; Jan Skov Jensen
Journal:  Cardiovasc Diabetol       Date:  2016-09-22       Impact factor: 9.951

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.